Page last updated: 2024-11-05

urethane and Muscular Diseases

urethane has been researched along with Muscular Diseases in 2 studies

Muscular Diseases: Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.

Research Excerpts

ExcerptRelevanceReference
"The enhanced effect of urethane anesthesia on the serum creatine kinase (CPK) level following administration of hypolipidemic agents was examined to develop a convenient experimental screening method for drug-induced myopathy."7.69Enhanced myopathy following administration of hypolipidemic agents under urethane anesthesia. ( Ichikawa, M; Matsuyama, K; Nakai, A; Nishikata, M; Uchida, T, 1997)
"The enhanced effect of urethane anesthesia on the serum creatine kinase (CPK) level following administration of hypolipidemic agents was examined to develop a convenient experimental screening method for drug-induced myopathy."3.69Enhanced myopathy following administration of hypolipidemic agents under urethane anesthesia. ( Ichikawa, M; Matsuyama, K; Nakai, A; Nishikata, M; Uchida, T, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakai, A2
Nishikata, M2
Uchida, T2
Ichikawa, M1
Matsuyama, K2
Nakagawa, K1
Konishi, Y1
Tanaka, H1

Other Studies

2 other studies available for urethane and Muscular Diseases

ArticleYear
Enhanced myopathy following administration of hypolipidemic agents under urethane anesthesia.
    Biological & pharmaceutical bulletin, 1997, Volume: 20, Issue:1

    Topics: Anesthesia; Animals; Bezafibrate; Calcium; Creatine Kinase; Hypolipidemic Agents; Lovastatin; Male;

1997
Evaluation of myopathy risk for HMG-CoA reductase inhibitors by urethane infusion method.
    Biological & pharmaceutical bulletin, 2002, Volume: 25, Issue:3

    Topics: Administration, Oral; Animals; Creatine Kinase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidn

2002